Log in with your NetID to export as a spreadsheet. After you log in, you will need to re-select any search options you've chosen.
Deadline |
Title | Funding Agency | Discipline | Who's Eligible | Award Amount | Date Posted |
|---|---|---|---|---|---|---|
| Deadline: 2/20/2024 | HEAL Initiative Notice of Special Interest (NOSI): Development and Validation of Pain-Related Models and Endpoints to Facilitate Non-Addictive Analgesic Discovery | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 11/06/2023 |
| Deadline: 2/20/2024 | Blueprint Medtech: Small Business Translator (U44 - Clinical Trial Optional) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 11/10/2023 |
| Deadline: 2/20/2024 | BRAIN Initiative: Next-Generation Invasive Devices for Recording and Modulation in the Human Central Nervous System (UG3/UH3 Clinical Trial Optional) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 11/10/2023 |
| Deadline: 2/20/2024 | Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Development and Validation of Model Systems to Facilitate Neurotherapeutic Discovery (R61/R33 Clinical Trial Not Allowed) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: $750,000 | 11/07/2023 |
| Deadline: 2/20/2024 | Blueprint MedTech Translator (UG3/UH3 - Clinical Trial Optional) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 11/10/2023 |
| Deadline: 2/20/2024 | Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies (R61/R33 Clinical Trial Not Allowed) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: $750,000 | 11/07/2023 |
| Deadline: 2/16/2024 | Alcohol Treatment, Pharmacotherapy, and Recovery Research (R34 Clinical Trial required) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: $450,000 | 11/14/2023 |
| Deadline: 2/16/2024 | Notice of Special Interest (NOSI): Technologies and Informatics Tools for Cancer Metabolomics | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 11/14/2023 |
| Deadline: 2/16/2024 | Notice of Special Interest (NOSI): Developing and Testing Multilevel Physical Activity Interventions to Improve Health and Well-Being | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 4/18/2022 |
| Deadline: 2/16/2024 | Notice of Special Interest (NOSI): Development of Innovative Informatics and Data Science Technologies, Tools, and Methods for Vision Research | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 11/14/2023 |
| Deadline: 2/16/2024 | Notice of Special Interest (NOSI): Secondary Analysis of Existing Datasets for Advancing Immune-mediated and Infectious Disease Research | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 11/16/2023 |
| Deadline: 2/16/2024 | NEI Translational Research Program for Therapeutics (R33 Clinical Trial Not Allowed) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: $3,000,000 | 11/14/2023 |
| Deadline: 2/16/2024 | Notice of Special Interest (NOSI): Administrative Supplements to Recognize Excellence in Diversity, Equity, Inclusion, and Accessibility (DEIA) Mentorship | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 10/30/2023 |
| Deadline: 2/16/2024 | NEI Translational Research Program for Therapeutics (R61/R33 Clinical Trial Not Allowed) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 9/06/2023 |
| Deadline: 2/15/2024 | Notice of Special Interest (NOSI): Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative Acceleration Award (UG3/UH3) (Clinical Trial Optional) for Advancing Recruitment through Trial Innovation Network (AR-TIN) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 11/10/2023 |
| Deadline: 2/15/2024 | Microphysiological Systems to Advance Precision Medicine for AD/ADRD Treatment and Prevention (U54 Clinical Trial Not Allowed) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: $12,500,000 | 10/20/2023 |
| Deadline: 2/15/2024 | Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative Acceleration Award (UG3/UH3 Clinical Trial Optional) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 11/06/2023 |
| Deadline: 2/15/2024 | Notice of Special Interest (NOSI): Collaborative and Innovative Research to Advance Regulatory Science: Partnership of FDA Centers of Excellence in Regulatory Science and Innovation (CERSI) and NIH Clinical and Translational Science Award (CTSA) Programs | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 11/06/2023 |
| Deadline: 2/14/2024 | Phased Research to Support Substance Use Epidemiology, Prevention, and Services Studies (R61/R33 Clinical Trials Optional) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 11/13/2023 |
| Deadline: 2/14/2024 | Notice of Intent to Publish a Funding Opportunity Announcement for Geroscience Course (R25 Independent Clinical Trial Not Allowed) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 10/24/2023 |
